CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Find insight on Novo Nordisk, European drug exports, and more in the latest Market Talks covering Health Care.

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

CVS Health’s Caremark business signed a new pharmacy benefits contract with the California Public Employees’ Retirement System, known as Calpers.

More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...

CVS Health Corporation CVS is gaining investor attention as the stock trends higher ahead of its second-quarter earnings ...

CVS Health, owner of Aetna, announced that Aetna will withdraw all Affordable Care Act (ACA) individual and family plans at ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost less," CVS Caremark told customers in May.

Pharmacy benefit manager CVS Caremark decided to replace Zepbound with Wegovy for use in weight loss starting July 1, despite Zepbound users having more weight loss success.